A Look Back: How Far Clinical Trial Technology Has Come
Digitalization has revolutionized an industry once reliant on paper collection.
Driving Clinical Speed and Agility Post-COVID
Improvements in data management and collaboration forge path to greater efficiency.
Sample Size Re-Estimation as an Adaptive Design
Using the promising-zone approach can salvage an underpowered trial.
Building Relationships Key for Smaller Sponsors
Strong collaboration critical as trial development advances.
Rebadging Gains Momentum Amidst COVID
Capacity management and stability offer value for clients, their employees and FSP vendors.
The Post-Pandemic CRO Landscape
Technology, talent and specialization add up to a plethora of industry M&As.
Amplifying Patient Voices in Protocol Design
Insights from studies on advisory boards and participation burden.
The State of IRT and RTSM Technologies
Elizabeth Rickenbacher, PhD, Director of Strategy for 4G Clinical discusses changes in the IRT and RTSM solutions.
Rhetoric and Realism Colliding on EU Discussions of Drug Repurposing
Slovenia brings EU health officials together for increased emphasis on repurposing.
Could Technology Supplant CROs?
A move back to in-house management of clinops could be on the horizon for sponsors.
Applied Clinical Trials September 2021 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials September 2021 issue in an interactive PDF format.
Biosimilars Move to Center Stage
All eyes are watching closely to see how well Viatris and Biocon Biologics’ Semglee, approved by FDA on July 28, competes with Sanofi’s well-established, long-acting insulin analog, Lantus.
